Ed two models. Model 1 was constructed using variables with P
Ed two models. Model 1 was constructed using variables with P
Ategories. Patients having ER-negative and PR-negative was designated as the ER/PR-negative group, and ER-positive or PR-positive as the ER/PR-positive group. Because significant interactions were observed between ER/PR status and the primary measures, and because the use of adjuvant endocrine therapy and prognosis varies according to ER/PR receptor status, we analyzed data according to ER/PR-posi
Receptor modulation and prognostic significance in primary breast cancer. J Natl Cancer Inst 2010, 102:54-68. 8. Ramadoss P, Marcus C, Perdew GH: Role of the aryl hydrocarbon receptor in drug metabolism. Expert Opin Drug Metab Toxicol 2005, 1:9-21. 9. Osborne CK, Schiff R, Fuqua SA, Shou J: Estrogen receptor: current understanding of its activation and modulation. Clin Cancer Res 2001, 7:4338s-434
Receptor modulation and prognostic significance in primary breast cancer. J Natl Cancer Inst 2010, 102:54-68. 8. Ramadoss P, Marcus C, Perdew GH: Role of the aryl hydrocarbon receptor in drug metabolism. Expert Opin Drug Metab Toxicol 2005, 1:9-21. 9. Osborne CK, Schiff R, Fuqua SA, Shou J: Estrogen receptor: current understanding of its activation and modulation. Clin Cancer Res 2001, 7:4338s-434
Istance, metabolic syndrome, and breast cancer recurrence: a cohort studySang Woo Oh1*, Cheol-Young Park2, Eun Sook Lee3, Yeong Sook Yoon4, Eon Sook Lee4, Sang Shin Park1,5, Yuil Kim1, Nak Jin Sung1, Young Ho Yun6, Keun Seok Lee7, Han Sung Kang7, Youngmee Kwon7 and Jungsil Ro7*AbstractIntroduction: Several in vitro studies have suggested the effects of adipokines and insulin resistance on breast c
Istance, metabolic syndrome, and breast cancer recurrence: a cohort studySang Woo Oh1*, Cheol-Young Park2, Eun Sook Lee3, Yeong Sook Yoon4, Eon Sook Lee4, Sang Shin Park1,5, Yuil Kim1, Nak Jin Sung1, Young Ho Yun6, Keun Seok Lee7, Han Sung Kang7, Youngmee Kwon7 and Jungsil Ro7*AbstractIntroduction: Several in vitro studies have suggested the effects of adipokines and insulin resistance on breast c
Of DC-SCRIPT are associated with reduced tumor aggressiveness. The association is particularly strong for small tumors with high ESR1 or low ESR2 mRNA levels or both. Finally, although DC-SCRIPT negatively regulates ESR1 and PGR activity, DC-SCRIPT levels measured in theSieuwerts et al. Breast Cancer Research 2010, 12:R103 http://breast-cancer-research.com/content/12/6/RPage 9 ofprimary tumors are